Nutritional Lifestyle Intervention in Obese Pregnant Women, Including Lower Carbohydrate Intake, Is Associated With Increased Maternal Free Fatty Acids, 3-β-Hydroxybutyrate, and Fasting Glucose Concentrations: A Secondary Factorial Analysis of the European Multicenter, Randomized Controlled DALI Lifestyle Intervention Trial

In our randomized controlled trial, we investigated the impact of healthy eating (HE) aiming for restricted gestational weight gain (GWG) and physical activity (PA) interventions on maternal and neonatal lipid metabolism. Obese pregnant women ( = 436) were included before 20 weeks' gestation an...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes care 2019-08, Vol.42 (8), p.1380-1389
Hauptverfasser: Harreiter, Jürgen, Simmons, David, Desoye, Gernot, Corcoy, Rosa, Adelantado, Juan M, Devlieger, Roland, Galjaard, Sander, Damm, Peter, Mathiesen, Elisabeth R, Jensen, Dorte M, Andersen, Lise Lotte T, Dunne, Fidelma, Lapolla, Annunziata, Dalfra, Maria G, Bertolotto, Alessandra, Wender-Ozegowska, Ewa, Zawiejska, Agnieszka, Mantaj, Urszula, Hill, David, Jelsma, Judith G M, Snoek, Frank J, Leutner, Michael, Lackinger, Christian, Worda, Christof, Bancher-Todesca, Dagmar, Scharnagl, Hubert, van Poppel, Mireille N M, Kautzky-Willer, Alexandra
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1389
container_issue 8
container_start_page 1380
container_title Diabetes care
container_volume 42
creator Harreiter, Jürgen
Simmons, David
Desoye, Gernot
Corcoy, Rosa
Adelantado, Juan M
Devlieger, Roland
Galjaard, Sander
Damm, Peter
Mathiesen, Elisabeth R
Jensen, Dorte M
Andersen, Lise Lotte T
Dunne, Fidelma
Lapolla, Annunziata
Dalfra, Maria G
Bertolotto, Alessandra
Wender-Ozegowska, Ewa
Zawiejska, Agnieszka
Mantaj, Urszula
Hill, David
Jelsma, Judith G M
Snoek, Frank J
Leutner, Michael
Lackinger, Christian
Worda, Christof
Bancher-Todesca, Dagmar
Scharnagl, Hubert
van Poppel, Mireille N M
Kautzky-Willer, Alexandra
description In our randomized controlled trial, we investigated the impact of healthy eating (HE) aiming for restricted gestational weight gain (GWG) and physical activity (PA) interventions on maternal and neonatal lipid metabolism. Obese pregnant women ( = 436) were included before 20 weeks' gestation and underwent glucose testing (oral glucose tolerance test) and lipid profiling at baseline and 24-28 and 35-37 gestational weeks after an at least 10-h overnight fast. This secondary analysis had a factorial design with comparison of HE ( = 221) versus no HE ( = 215) and PA ( = 218) versus no PA ( = 218). Maternal changes in triglycerides (TG), LDL cholesterol, HDL cholesterol, free fatty acids (FFAs), and leptin from baseline to end of pregnancy and neonatal outcomes were analyzed using general linear models with adjustment for relevant parameters. At 24-28 weeks' gestation, FFAs (mean ± SD, 0.60 ± 0.19 vs. 0.55 ± 0.17 mmol/L, < 0.01) were increased after adjustment for FFA at baseline, maternal age, BMI at time of examination, gestational week, insulin resistance, self-reported food intake, self-reported physical activity, and maternal smoking, and GWG was lower (3.3 ± 2.6 vs. 4.3 ± 2.8 kg, < 0.001, adjusted mean differences -1.0 [95% CI -1.5; -0.5]) in HE versus no HE. Fasting glucose levels (4.7 ± 0.4 vs. 4.6 ± 0.4 mmol/L, < 0.05) and 3-β-hydroxybutyrate (3BHB) (0.082 ± 0.065 vs. 0.068 ± 0.067 mmol/L, < 0.05) were higher in HE. Significant negative associations between carbohydrate intake and FFA, 3BHB, and fasting glucose at 24-28 weeks' gestation were observed. No differences between groups were found in oral glucose tolerance test or leptin or TG levels at any time. Furthermore, in PA versus no PA, no similar changes were found. In cord blood, elevated FFA levels were found in HE after full adjustment (0.34 ± 0.22 vs. 0.29 ± 0.16 mmol/L, = 0.01). HE intervention was associated with reduced GWG, higher FFAs, higher 3BHB, and higher fasting glucose at 24-28 weeks of gestation, suggesting induction of lipolysis. Increased FFA was negatively associated with carbohydrate intake and was also observed in cord blood. These findings support the hypothesis that maternal antenatal dietary restriction including carbohydrates is associated with increased FFA mobilization.
doi_str_mv 10.2337/dc19-0418
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2340045859</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2340045859</sourcerecordid><originalsourceid>FETCH-LOGICAL-c278t-510cddc922353e2ada68e983933d262bee6316297a89bf94823b259da2afa3cb3</originalsourceid><addsrcrecordid>eNp1ksFu1DAQhgMC0aVw4AWQJS4gbSCxk12bW7R025W2FEFRj5FjT1qXrL3YDhAeiwfhmRjTwgGJk-3x5___NZ4se1IWLyljy1dalSIvqpLfzWalYHVe1xW_l82KshJ5LQQ9yB6GcF0URVVx_iA7YGXJaSXo7M767Ri9icZZOZCt6SHEaQCysRH8F7DpghhLzjoIQN55uLTSRnLhdmDnSKlh1MZekq37Cp6spO_c1aS9jL8l5CdAKJAmBKcMFjW5MPEqvfMgAx5PseiT9doDkLWMcSKNMjrMCct__shPUMx9m7oxTkl0TqTViIWYTI-HUTmMtXJWYVQEMG14TRryAZSzWvoJWRWdN-jQoM0UTCCuJ_EKyNHo3R6kJafjEE0SAD8n79HA7cx3zIay0bthwO2bZrv5X3fOk_qj7H4vhwCPb9fD7OP66Hx1km_PjjerZpsruuQxr8tCaa0EpaxmQKWWCw6CM8GYpgvaASxYuaBiKbnoelFxyjpaCy2p7CVTHTvMnt_o7r37PGKcdmeCgmGQFtwYWsoq_OSa1wLRZ_-g125MvUaKLlnJxaJgSL24oZR3IXjo2703O-xcWxZtGq42DVebhgvZp7eKY7cD_Zf8M03sF7FO0Mg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2273189603</pqid></control><display><type>article</type><title>Nutritional Lifestyle Intervention in Obese Pregnant Women, Including Lower Carbohydrate Intake, Is Associated With Increased Maternal Free Fatty Acids, 3-β-Hydroxybutyrate, and Fasting Glucose Concentrations: A Secondary Factorial Analysis of the European Multicenter, Randomized Controlled DALI Lifestyle Intervention Trial</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Harreiter, Jürgen ; Simmons, David ; Desoye, Gernot ; Corcoy, Rosa ; Adelantado, Juan M ; Devlieger, Roland ; Galjaard, Sander ; Damm, Peter ; Mathiesen, Elisabeth R ; Jensen, Dorte M ; Andersen, Lise Lotte T ; Dunne, Fidelma ; Lapolla, Annunziata ; Dalfra, Maria G ; Bertolotto, Alessandra ; Wender-Ozegowska, Ewa ; Zawiejska, Agnieszka ; Mantaj, Urszula ; Hill, David ; Jelsma, Judith G M ; Snoek, Frank J ; Leutner, Michael ; Lackinger, Christian ; Worda, Christof ; Bancher-Todesca, Dagmar ; Scharnagl, Hubert ; van Poppel, Mireille N M ; Kautzky-Willer, Alexandra</creator><creatorcontrib>Harreiter, Jürgen ; Simmons, David ; Desoye, Gernot ; Corcoy, Rosa ; Adelantado, Juan M ; Devlieger, Roland ; Galjaard, Sander ; Damm, Peter ; Mathiesen, Elisabeth R ; Jensen, Dorte M ; Andersen, Lise Lotte T ; Dunne, Fidelma ; Lapolla, Annunziata ; Dalfra, Maria G ; Bertolotto, Alessandra ; Wender-Ozegowska, Ewa ; Zawiejska, Agnieszka ; Mantaj, Urszula ; Hill, David ; Jelsma, Judith G M ; Snoek, Frank J ; Leutner, Michael ; Lackinger, Christian ; Worda, Christof ; Bancher-Todesca, Dagmar ; Scharnagl, Hubert ; van Poppel, Mireille N M ; Kautzky-Willer, Alexandra</creatorcontrib><description>In our randomized controlled trial, we investigated the impact of healthy eating (HE) aiming for restricted gestational weight gain (GWG) and physical activity (PA) interventions on maternal and neonatal lipid metabolism. Obese pregnant women ( = 436) were included before 20 weeks' gestation and underwent glucose testing (oral glucose tolerance test) and lipid profiling at baseline and 24-28 and 35-37 gestational weeks after an at least 10-h overnight fast. This secondary analysis had a factorial design with comparison of HE ( = 221) versus no HE ( = 215) and PA ( = 218) versus no PA ( = 218). Maternal changes in triglycerides (TG), LDL cholesterol, HDL cholesterol, free fatty acids (FFAs), and leptin from baseline to end of pregnancy and neonatal outcomes were analyzed using general linear models with adjustment for relevant parameters. At 24-28 weeks' gestation, FFAs (mean ± SD, 0.60 ± 0.19 vs. 0.55 ± 0.17 mmol/L, &lt; 0.01) were increased after adjustment for FFA at baseline, maternal age, BMI at time of examination, gestational week, insulin resistance, self-reported food intake, self-reported physical activity, and maternal smoking, and GWG was lower (3.3 ± 2.6 vs. 4.3 ± 2.8 kg, &lt; 0.001, adjusted mean differences -1.0 [95% CI -1.5; -0.5]) in HE versus no HE. Fasting glucose levels (4.7 ± 0.4 vs. 4.6 ± 0.4 mmol/L, &lt; 0.05) and 3-β-hydroxybutyrate (3BHB) (0.082 ± 0.065 vs. 0.068 ± 0.067 mmol/L, &lt; 0.05) were higher in HE. Significant negative associations between carbohydrate intake and FFA, 3BHB, and fasting glucose at 24-28 weeks' gestation were observed. No differences between groups were found in oral glucose tolerance test or leptin or TG levels at any time. Furthermore, in PA versus no PA, no similar changes were found. In cord blood, elevated FFA levels were found in HE after full adjustment (0.34 ± 0.22 vs. 0.29 ± 0.16 mmol/L, = 0.01). HE intervention was associated with reduced GWG, higher FFAs, higher 3BHB, and higher fasting glucose at 24-28 weeks of gestation, suggesting induction of lipolysis. Increased FFA was negatively associated with carbohydrate intake and was also observed in cord blood. These findings support the hypothesis that maternal antenatal dietary restriction including carbohydrates is associated with increased FFA mobilization.</description><identifier>ISSN: 0149-5992</identifier><identifier>EISSN: 1935-5548</identifier><identifier>DOI: 10.2337/dc19-0418</identifier><identifier>PMID: 31182492</identifier><language>eng</language><publisher>United States: American Diabetes Association</publisher><subject>3-Hydroxybutyric Acid - blood ; Adult ; Blood ; Blood Glucose - analysis ; Body weight gain ; Carbohydrates ; Cholesterol ; Cholesterol, HDL - blood ; Cholesterol, LDL - blood ; Cord blood ; Diet ; Diet, Healthy - methods ; Dietary Carbohydrates - pharmacology ; Dietary restrictions ; Europe ; Exercise - physiology ; Factor Analysis, Statistical ; Factorial analysis ; Factorial design ; Fasting ; Fatty acids ; Fatty Acids, Nonesterified - blood ; Female ; Food intake ; Gestation ; Gestational Weight Gain ; Glucose ; Glucose tolerance ; Glucose Tolerance Test ; High density lipoprotein ; Humans ; Hydroxybutyrates ; Insulin ; Insulin Resistance ; Intervention ; Laboratory testing ; Leptin ; Leptin - blood ; Life Style ; Linear Models ; Lipid metabolism ; Lipids ; Lipolysis ; Low density lipoprotein ; Neonates ; Obesity ; Obesity - blood ; Obesity - therapy ; Physical activity ; Pregnancy ; Pregnancy Complications - blood ; Pregnancy Complications - therapy ; Prenatal Care - methods ; Randomization ; Research design ; Secondary analysis ; Smoking ; Treatment Outcome ; Triglycerides ; Triglycerides - blood ; Weight Gain ; Womens health</subject><ispartof>Diabetes care, 2019-08, Vol.42 (8), p.1380-1389</ispartof><rights>2019 by the American Diabetes Association.</rights><rights>Copyright American Diabetes Association Aug 1, 2019</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c278t-510cddc922353e2ada68e983933d262bee6316297a89bf94823b259da2afa3cb3</citedby><cites>FETCH-LOGICAL-c278t-510cddc922353e2ada68e983933d262bee6316297a89bf94823b259da2afa3cb3</cites><orcidid>0000-0001-5055-6814 ; 0000-0002-5715-3230 ; 0000-0002-3520-4105</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31182492$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Harreiter, Jürgen</creatorcontrib><creatorcontrib>Simmons, David</creatorcontrib><creatorcontrib>Desoye, Gernot</creatorcontrib><creatorcontrib>Corcoy, Rosa</creatorcontrib><creatorcontrib>Adelantado, Juan M</creatorcontrib><creatorcontrib>Devlieger, Roland</creatorcontrib><creatorcontrib>Galjaard, Sander</creatorcontrib><creatorcontrib>Damm, Peter</creatorcontrib><creatorcontrib>Mathiesen, Elisabeth R</creatorcontrib><creatorcontrib>Jensen, Dorte M</creatorcontrib><creatorcontrib>Andersen, Lise Lotte T</creatorcontrib><creatorcontrib>Dunne, Fidelma</creatorcontrib><creatorcontrib>Lapolla, Annunziata</creatorcontrib><creatorcontrib>Dalfra, Maria G</creatorcontrib><creatorcontrib>Bertolotto, Alessandra</creatorcontrib><creatorcontrib>Wender-Ozegowska, Ewa</creatorcontrib><creatorcontrib>Zawiejska, Agnieszka</creatorcontrib><creatorcontrib>Mantaj, Urszula</creatorcontrib><creatorcontrib>Hill, David</creatorcontrib><creatorcontrib>Jelsma, Judith G M</creatorcontrib><creatorcontrib>Snoek, Frank J</creatorcontrib><creatorcontrib>Leutner, Michael</creatorcontrib><creatorcontrib>Lackinger, Christian</creatorcontrib><creatorcontrib>Worda, Christof</creatorcontrib><creatorcontrib>Bancher-Todesca, Dagmar</creatorcontrib><creatorcontrib>Scharnagl, Hubert</creatorcontrib><creatorcontrib>van Poppel, Mireille N M</creatorcontrib><creatorcontrib>Kautzky-Willer, Alexandra</creatorcontrib><title>Nutritional Lifestyle Intervention in Obese Pregnant Women, Including Lower Carbohydrate Intake, Is Associated With Increased Maternal Free Fatty Acids, 3-β-Hydroxybutyrate, and Fasting Glucose Concentrations: A Secondary Factorial Analysis of the European Multicenter, Randomized Controlled DALI Lifestyle Intervention Trial</title><title>Diabetes care</title><addtitle>Diabetes Care</addtitle><description>In our randomized controlled trial, we investigated the impact of healthy eating (HE) aiming for restricted gestational weight gain (GWG) and physical activity (PA) interventions on maternal and neonatal lipid metabolism. Obese pregnant women ( = 436) were included before 20 weeks' gestation and underwent glucose testing (oral glucose tolerance test) and lipid profiling at baseline and 24-28 and 35-37 gestational weeks after an at least 10-h overnight fast. This secondary analysis had a factorial design with comparison of HE ( = 221) versus no HE ( = 215) and PA ( = 218) versus no PA ( = 218). Maternal changes in triglycerides (TG), LDL cholesterol, HDL cholesterol, free fatty acids (FFAs), and leptin from baseline to end of pregnancy and neonatal outcomes were analyzed using general linear models with adjustment for relevant parameters. At 24-28 weeks' gestation, FFAs (mean ± SD, 0.60 ± 0.19 vs. 0.55 ± 0.17 mmol/L, &lt; 0.01) were increased after adjustment for FFA at baseline, maternal age, BMI at time of examination, gestational week, insulin resistance, self-reported food intake, self-reported physical activity, and maternal smoking, and GWG was lower (3.3 ± 2.6 vs. 4.3 ± 2.8 kg, &lt; 0.001, adjusted mean differences -1.0 [95% CI -1.5; -0.5]) in HE versus no HE. Fasting glucose levels (4.7 ± 0.4 vs. 4.6 ± 0.4 mmol/L, &lt; 0.05) and 3-β-hydroxybutyrate (3BHB) (0.082 ± 0.065 vs. 0.068 ± 0.067 mmol/L, &lt; 0.05) were higher in HE. Significant negative associations between carbohydrate intake and FFA, 3BHB, and fasting glucose at 24-28 weeks' gestation were observed. No differences between groups were found in oral glucose tolerance test or leptin or TG levels at any time. Furthermore, in PA versus no PA, no similar changes were found. In cord blood, elevated FFA levels were found in HE after full adjustment (0.34 ± 0.22 vs. 0.29 ± 0.16 mmol/L, = 0.01). HE intervention was associated with reduced GWG, higher FFAs, higher 3BHB, and higher fasting glucose at 24-28 weeks of gestation, suggesting induction of lipolysis. Increased FFA was negatively associated with carbohydrate intake and was also observed in cord blood. These findings support the hypothesis that maternal antenatal dietary restriction including carbohydrates is associated with increased FFA mobilization.</description><subject>3-Hydroxybutyric Acid - blood</subject><subject>Adult</subject><subject>Blood</subject><subject>Blood Glucose - analysis</subject><subject>Body weight gain</subject><subject>Carbohydrates</subject><subject>Cholesterol</subject><subject>Cholesterol, HDL - blood</subject><subject>Cholesterol, LDL - blood</subject><subject>Cord blood</subject><subject>Diet</subject><subject>Diet, Healthy - methods</subject><subject>Dietary Carbohydrates - pharmacology</subject><subject>Dietary restrictions</subject><subject>Europe</subject><subject>Exercise - physiology</subject><subject>Factor Analysis, Statistical</subject><subject>Factorial analysis</subject><subject>Factorial design</subject><subject>Fasting</subject><subject>Fatty acids</subject><subject>Fatty Acids, Nonesterified - blood</subject><subject>Female</subject><subject>Food intake</subject><subject>Gestation</subject><subject>Gestational Weight Gain</subject><subject>Glucose</subject><subject>Glucose tolerance</subject><subject>Glucose Tolerance Test</subject><subject>High density lipoprotein</subject><subject>Humans</subject><subject>Hydroxybutyrates</subject><subject>Insulin</subject><subject>Insulin Resistance</subject><subject>Intervention</subject><subject>Laboratory testing</subject><subject>Leptin</subject><subject>Leptin - blood</subject><subject>Life Style</subject><subject>Linear Models</subject><subject>Lipid metabolism</subject><subject>Lipids</subject><subject>Lipolysis</subject><subject>Low density lipoprotein</subject><subject>Neonates</subject><subject>Obesity</subject><subject>Obesity - blood</subject><subject>Obesity - therapy</subject><subject>Physical activity</subject><subject>Pregnancy</subject><subject>Pregnancy Complications - blood</subject><subject>Pregnancy Complications - therapy</subject><subject>Prenatal Care - methods</subject><subject>Randomization</subject><subject>Research design</subject><subject>Secondary analysis</subject><subject>Smoking</subject><subject>Treatment Outcome</subject><subject>Triglycerides</subject><subject>Triglycerides - blood</subject><subject>Weight Gain</subject><subject>Womens health</subject><issn>0149-5992</issn><issn>1935-5548</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1ksFu1DAQhgMC0aVw4AWQJS4gbSCxk12bW7R025W2FEFRj5FjT1qXrL3YDhAeiwfhmRjTwgGJk-3x5___NZ4se1IWLyljy1dalSIvqpLfzWalYHVe1xW_l82KshJ5LQQ9yB6GcF0URVVx_iA7YGXJaSXo7M767Ri9icZZOZCt6SHEaQCysRH8F7DpghhLzjoIQN55uLTSRnLhdmDnSKlh1MZekq37Cp6spO_c1aS9jL8l5CdAKJAmBKcMFjW5MPEqvfMgAx5PseiT9doDkLWMcSKNMjrMCct__shPUMx9m7oxTkl0TqTViIWYTI-HUTmMtXJWYVQEMG14TRryAZSzWvoJWRWdN-jQoM0UTCCuJ_EKyNHo3R6kJafjEE0SAD8n79HA7cx3zIay0bthwO2bZrv5X3fOk_qj7H4vhwCPb9fD7OP66Hx1km_PjjerZpsruuQxr8tCaa0EpaxmQKWWCw6CM8GYpgvaASxYuaBiKbnoelFxyjpaCy2p7CVTHTvMnt_o7r37PGKcdmeCgmGQFtwYWsoq_OSa1wLRZ_-g125MvUaKLlnJxaJgSL24oZR3IXjo2703O-xcWxZtGq42DVebhgvZp7eKY7cD_Zf8M03sF7FO0Mg</recordid><startdate>201908</startdate><enddate>201908</enddate><creator>Harreiter, Jürgen</creator><creator>Simmons, David</creator><creator>Desoye, Gernot</creator><creator>Corcoy, Rosa</creator><creator>Adelantado, Juan M</creator><creator>Devlieger, Roland</creator><creator>Galjaard, Sander</creator><creator>Damm, Peter</creator><creator>Mathiesen, Elisabeth R</creator><creator>Jensen, Dorte M</creator><creator>Andersen, Lise Lotte T</creator><creator>Dunne, Fidelma</creator><creator>Lapolla, Annunziata</creator><creator>Dalfra, Maria G</creator><creator>Bertolotto, Alessandra</creator><creator>Wender-Ozegowska, Ewa</creator><creator>Zawiejska, Agnieszka</creator><creator>Mantaj, Urszula</creator><creator>Hill, David</creator><creator>Jelsma, Judith G M</creator><creator>Snoek, Frank J</creator><creator>Leutner, Michael</creator><creator>Lackinger, Christian</creator><creator>Worda, Christof</creator><creator>Bancher-Todesca, Dagmar</creator><creator>Scharnagl, Hubert</creator><creator>van Poppel, Mireille N M</creator><creator>Kautzky-Willer, Alexandra</creator><general>American Diabetes Association</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-5055-6814</orcidid><orcidid>https://orcid.org/0000-0002-5715-3230</orcidid><orcidid>https://orcid.org/0000-0002-3520-4105</orcidid></search><sort><creationdate>201908</creationdate><title>Nutritional Lifestyle Intervention in Obese Pregnant Women, Including Lower Carbohydrate Intake, Is Associated With Increased Maternal Free Fatty Acids, 3-β-Hydroxybutyrate, and Fasting Glucose Concentrations: A Secondary Factorial Analysis of the European Multicenter, Randomized Controlled DALI Lifestyle Intervention Trial</title><author>Harreiter, Jürgen ; Simmons, David ; Desoye, Gernot ; Corcoy, Rosa ; Adelantado, Juan M ; Devlieger, Roland ; Galjaard, Sander ; Damm, Peter ; Mathiesen, Elisabeth R ; Jensen, Dorte M ; Andersen, Lise Lotte T ; Dunne, Fidelma ; Lapolla, Annunziata ; Dalfra, Maria G ; Bertolotto, Alessandra ; Wender-Ozegowska, Ewa ; Zawiejska, Agnieszka ; Mantaj, Urszula ; Hill, David ; Jelsma, Judith G M ; Snoek, Frank J ; Leutner, Michael ; Lackinger, Christian ; Worda, Christof ; Bancher-Todesca, Dagmar ; Scharnagl, Hubert ; van Poppel, Mireille N M ; Kautzky-Willer, Alexandra</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c278t-510cddc922353e2ada68e983933d262bee6316297a89bf94823b259da2afa3cb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>3-Hydroxybutyric Acid - blood</topic><topic>Adult</topic><topic>Blood</topic><topic>Blood Glucose - analysis</topic><topic>Body weight gain</topic><topic>Carbohydrates</topic><topic>Cholesterol</topic><topic>Cholesterol, HDL - blood</topic><topic>Cholesterol, LDL - blood</topic><topic>Cord blood</topic><topic>Diet</topic><topic>Diet, Healthy - methods</topic><topic>Dietary Carbohydrates - pharmacology</topic><topic>Dietary restrictions</topic><topic>Europe</topic><topic>Exercise - physiology</topic><topic>Factor Analysis, Statistical</topic><topic>Factorial analysis</topic><topic>Factorial design</topic><topic>Fasting</topic><topic>Fatty acids</topic><topic>Fatty Acids, Nonesterified - blood</topic><topic>Female</topic><topic>Food intake</topic><topic>Gestation</topic><topic>Gestational Weight Gain</topic><topic>Glucose</topic><topic>Glucose tolerance</topic><topic>Glucose Tolerance Test</topic><topic>High density lipoprotein</topic><topic>Humans</topic><topic>Hydroxybutyrates</topic><topic>Insulin</topic><topic>Insulin Resistance</topic><topic>Intervention</topic><topic>Laboratory testing</topic><topic>Leptin</topic><topic>Leptin - blood</topic><topic>Life Style</topic><topic>Linear Models</topic><topic>Lipid metabolism</topic><topic>Lipids</topic><topic>Lipolysis</topic><topic>Low density lipoprotein</topic><topic>Neonates</topic><topic>Obesity</topic><topic>Obesity - blood</topic><topic>Obesity - therapy</topic><topic>Physical activity</topic><topic>Pregnancy</topic><topic>Pregnancy Complications - blood</topic><topic>Pregnancy Complications - therapy</topic><topic>Prenatal Care - methods</topic><topic>Randomization</topic><topic>Research design</topic><topic>Secondary analysis</topic><topic>Smoking</topic><topic>Treatment Outcome</topic><topic>Triglycerides</topic><topic>Triglycerides - blood</topic><topic>Weight Gain</topic><topic>Womens health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Harreiter, Jürgen</creatorcontrib><creatorcontrib>Simmons, David</creatorcontrib><creatorcontrib>Desoye, Gernot</creatorcontrib><creatorcontrib>Corcoy, Rosa</creatorcontrib><creatorcontrib>Adelantado, Juan M</creatorcontrib><creatorcontrib>Devlieger, Roland</creatorcontrib><creatorcontrib>Galjaard, Sander</creatorcontrib><creatorcontrib>Damm, Peter</creatorcontrib><creatorcontrib>Mathiesen, Elisabeth R</creatorcontrib><creatorcontrib>Jensen, Dorte M</creatorcontrib><creatorcontrib>Andersen, Lise Lotte T</creatorcontrib><creatorcontrib>Dunne, Fidelma</creatorcontrib><creatorcontrib>Lapolla, Annunziata</creatorcontrib><creatorcontrib>Dalfra, Maria G</creatorcontrib><creatorcontrib>Bertolotto, Alessandra</creatorcontrib><creatorcontrib>Wender-Ozegowska, Ewa</creatorcontrib><creatorcontrib>Zawiejska, Agnieszka</creatorcontrib><creatorcontrib>Mantaj, Urszula</creatorcontrib><creatorcontrib>Hill, David</creatorcontrib><creatorcontrib>Jelsma, Judith G M</creatorcontrib><creatorcontrib>Snoek, Frank J</creatorcontrib><creatorcontrib>Leutner, Michael</creatorcontrib><creatorcontrib>Lackinger, Christian</creatorcontrib><creatorcontrib>Worda, Christof</creatorcontrib><creatorcontrib>Bancher-Todesca, Dagmar</creatorcontrib><creatorcontrib>Scharnagl, Hubert</creatorcontrib><creatorcontrib>van Poppel, Mireille N M</creatorcontrib><creatorcontrib>Kautzky-Willer, Alexandra</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Diabetes care</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Harreiter, Jürgen</au><au>Simmons, David</au><au>Desoye, Gernot</au><au>Corcoy, Rosa</au><au>Adelantado, Juan M</au><au>Devlieger, Roland</au><au>Galjaard, Sander</au><au>Damm, Peter</au><au>Mathiesen, Elisabeth R</au><au>Jensen, Dorte M</au><au>Andersen, Lise Lotte T</au><au>Dunne, Fidelma</au><au>Lapolla, Annunziata</au><au>Dalfra, Maria G</au><au>Bertolotto, Alessandra</au><au>Wender-Ozegowska, Ewa</au><au>Zawiejska, Agnieszka</au><au>Mantaj, Urszula</au><au>Hill, David</au><au>Jelsma, Judith G M</au><au>Snoek, Frank J</au><au>Leutner, Michael</au><au>Lackinger, Christian</au><au>Worda, Christof</au><au>Bancher-Todesca, Dagmar</au><au>Scharnagl, Hubert</au><au>van Poppel, Mireille N M</au><au>Kautzky-Willer, Alexandra</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Nutritional Lifestyle Intervention in Obese Pregnant Women, Including Lower Carbohydrate Intake, Is Associated With Increased Maternal Free Fatty Acids, 3-β-Hydroxybutyrate, and Fasting Glucose Concentrations: A Secondary Factorial Analysis of the European Multicenter, Randomized Controlled DALI Lifestyle Intervention Trial</atitle><jtitle>Diabetes care</jtitle><addtitle>Diabetes Care</addtitle><date>2019-08</date><risdate>2019</risdate><volume>42</volume><issue>8</issue><spage>1380</spage><epage>1389</epage><pages>1380-1389</pages><issn>0149-5992</issn><eissn>1935-5548</eissn><abstract>In our randomized controlled trial, we investigated the impact of healthy eating (HE) aiming for restricted gestational weight gain (GWG) and physical activity (PA) interventions on maternal and neonatal lipid metabolism. Obese pregnant women ( = 436) were included before 20 weeks' gestation and underwent glucose testing (oral glucose tolerance test) and lipid profiling at baseline and 24-28 and 35-37 gestational weeks after an at least 10-h overnight fast. This secondary analysis had a factorial design with comparison of HE ( = 221) versus no HE ( = 215) and PA ( = 218) versus no PA ( = 218). Maternal changes in triglycerides (TG), LDL cholesterol, HDL cholesterol, free fatty acids (FFAs), and leptin from baseline to end of pregnancy and neonatal outcomes were analyzed using general linear models with adjustment for relevant parameters. At 24-28 weeks' gestation, FFAs (mean ± SD, 0.60 ± 0.19 vs. 0.55 ± 0.17 mmol/L, &lt; 0.01) were increased after adjustment for FFA at baseline, maternal age, BMI at time of examination, gestational week, insulin resistance, self-reported food intake, self-reported physical activity, and maternal smoking, and GWG was lower (3.3 ± 2.6 vs. 4.3 ± 2.8 kg, &lt; 0.001, adjusted mean differences -1.0 [95% CI -1.5; -0.5]) in HE versus no HE. Fasting glucose levels (4.7 ± 0.4 vs. 4.6 ± 0.4 mmol/L, &lt; 0.05) and 3-β-hydroxybutyrate (3BHB) (0.082 ± 0.065 vs. 0.068 ± 0.067 mmol/L, &lt; 0.05) were higher in HE. Significant negative associations between carbohydrate intake and FFA, 3BHB, and fasting glucose at 24-28 weeks' gestation were observed. No differences between groups were found in oral glucose tolerance test or leptin or TG levels at any time. Furthermore, in PA versus no PA, no similar changes were found. In cord blood, elevated FFA levels were found in HE after full adjustment (0.34 ± 0.22 vs. 0.29 ± 0.16 mmol/L, = 0.01). HE intervention was associated with reduced GWG, higher FFAs, higher 3BHB, and higher fasting glucose at 24-28 weeks of gestation, suggesting induction of lipolysis. Increased FFA was negatively associated with carbohydrate intake and was also observed in cord blood. These findings support the hypothesis that maternal antenatal dietary restriction including carbohydrates is associated with increased FFA mobilization.</abstract><cop>United States</cop><pub>American Diabetes Association</pub><pmid>31182492</pmid><doi>10.2337/dc19-0418</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0001-5055-6814</orcidid><orcidid>https://orcid.org/0000-0002-5715-3230</orcidid><orcidid>https://orcid.org/0000-0002-3520-4105</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0149-5992
ispartof Diabetes care, 2019-08, Vol.42 (8), p.1380-1389
issn 0149-5992
1935-5548
language eng
recordid cdi_proquest_miscellaneous_2340045859
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects 3-Hydroxybutyric Acid - blood
Adult
Blood
Blood Glucose - analysis
Body weight gain
Carbohydrates
Cholesterol
Cholesterol, HDL - blood
Cholesterol, LDL - blood
Cord blood
Diet
Diet, Healthy - methods
Dietary Carbohydrates - pharmacology
Dietary restrictions
Europe
Exercise - physiology
Factor Analysis, Statistical
Factorial analysis
Factorial design
Fasting
Fatty acids
Fatty Acids, Nonesterified - blood
Female
Food intake
Gestation
Gestational Weight Gain
Glucose
Glucose tolerance
Glucose Tolerance Test
High density lipoprotein
Humans
Hydroxybutyrates
Insulin
Insulin Resistance
Intervention
Laboratory testing
Leptin
Leptin - blood
Life Style
Linear Models
Lipid metabolism
Lipids
Lipolysis
Low density lipoprotein
Neonates
Obesity
Obesity - blood
Obesity - therapy
Physical activity
Pregnancy
Pregnancy Complications - blood
Pregnancy Complications - therapy
Prenatal Care - methods
Randomization
Research design
Secondary analysis
Smoking
Treatment Outcome
Triglycerides
Triglycerides - blood
Weight Gain
Womens health
title Nutritional Lifestyle Intervention in Obese Pregnant Women, Including Lower Carbohydrate Intake, Is Associated With Increased Maternal Free Fatty Acids, 3-β-Hydroxybutyrate, and Fasting Glucose Concentrations: A Secondary Factorial Analysis of the European Multicenter, Randomized Controlled DALI Lifestyle Intervention Trial
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T17%3A42%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Nutritional%20Lifestyle%20Intervention%20in%20Obese%20Pregnant%20Women,%20Including%20Lower%20Carbohydrate%20Intake,%20Is%20Associated%20With%20Increased%20Maternal%20Free%20Fatty%20Acids,%203-%CE%B2-Hydroxybutyrate,%20and%20Fasting%20Glucose%20Concentrations:%20A%20Secondary%20Factorial%20Analysis%20of%20the%20European%20Multicenter,%20Randomized%20Controlled%20DALI%20Lifestyle%20Intervention%20Trial&rft.jtitle=Diabetes%20care&rft.au=Harreiter,%20J%C3%BCrgen&rft.date=2019-08&rft.volume=42&rft.issue=8&rft.spage=1380&rft.epage=1389&rft.pages=1380-1389&rft.issn=0149-5992&rft.eissn=1935-5548&rft_id=info:doi/10.2337/dc19-0418&rft_dat=%3Cproquest_cross%3E2340045859%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2273189603&rft_id=info:pmid/31182492&rfr_iscdi=true